Asthma Clinical Trials in Bari
3 recruitingBari, Italy
Showing 1–3 of 3 trials
Recruiting
Phase 3
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
Eosinophilic Asthma
AstraZeneca400 enrolled157 locationsNCT06750289
Recruiting
A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy
Severe Eosinophilic Asthma
AstraZeneca335 enrolled28 locationsNCT07214753
Recruiting
Observational Study on the Clinical Profile of Patients With Uncontrolled Severe Asthma Treated With Tezepelumab in Italy
Asthma
AstraZeneca300 enrolled30 locationsNCT06948396